U.S. health regulator approves Teva's migraine drug
The world's largest generic drugmaker had hoped to receive approval for the injectable drug, fremanezumab, by June.
- Country:
- United States
The world's largest generic drugmaker had hoped to receive approval for the injectable drug, fremanezumab, by June. Its release was delayed due to U.S. regulatory concerns about the manufacturing process at the South Korean plant of its development partner Celltrion.
Around 39 million Americans suffer from migraine headaches, according to the Migraine Research Foundation, making for a large market that has attracted several drugmakers.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
Advertisement
ALSO READ
Ghulam Nabi Azad Vows to Combat Drug Abuse and Secure Youth Employment in J&K
Major Drug Bust in Assam: Three Arrested, 120,000 Yaba Tablets Seized
Court Denies Bail to Singer in Heinous Drugs Case
FDA Seizes Rs 6 Lakh Worth of Ayurvedic Drugs in Thane Raid
Manipur CM: 'War on Drugs' Not Targeted at Specific Community